Literature DB >> 12200228

Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.

L K Beitel1, Y A Elhaji, R Lumbroso, S S Wing, V Panet-Raymond, B Gottlieb, L Pinsky, M A Trifiro.   

Abstract

The androgen receptor (AR) N-terminal domain plays a critical role in androgen-responsive gene regulation. A novel AR N-terminal-interacting protein (ARNIP) was isolated using the yeast two-hybrid system and its interaction with amino acids 11-172 of the normal or corresponding region of the polyglutamine-expanded human AR confirmed by glutathione S-transferase pulldown assays. ARNIP cDNAs cloned from NSC-34 (mouse neuroblastoma/spinal cord) or PC-3 (human prostate adenocarcinoma) mRNA encoded highly homologous 30 kDa (261 amino acids) cysteine-rich proteins with a RING-H2 (C3H2C3 zinc finger) domain; this motif is highly conserved in predicted ARNIP-homologous proteins from several other species. Expression of the approximately 1.7 kb ARNIP mRNA was detected in various tissues by Northern blotting, but was highest in mouse testes, kidney and several neuronal cell lines. In addition, the human ARNIP protein was found to be encoded by nine exons spanning 32 kb on chromosome 4q21. In COS-1 cells, coexpression of ARNIP and AR did not affect AR ligand-binding kinetics, nor did ARNIP act as a coactivator or corepressor in transactivation assays. However, AR N-terminal:C-terminal interaction was reduced in the presence of ARNIP. Intriguingly, ARNIP, and in particular its RING-H2 domain, functioned as a ubiquitin-protein ligase in vitro in the presence of a specific ubiquitin-conjugating enzyme, Ubc4-1. Mutation of a single cysteine residue in the ARNIP RING-H2 domain (Cys145Ala) abolished this E3 ubiquitin ligase activity. Fluorescent protein tagging studies revealed that AR-ARNIP interaction was hormone-independent in COS-1 cells, and suggest that colocalization of both AR and ARNIP to the nucleus upon androgen addition may allow ARNIP to play a role in nuclear processes. Thus, identification of a novel AR-interacting protein with ubiquitin ligase activity will stimulate further investigation into the role of ubiquitination and the ubiquitin-proteasome system in AR-mediated cellular functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200228     DOI: 10.1677/jme.0.0290041

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  34 in total

1.  Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones.

Authors:  Zhiqian Liu; Rose Oughtred; Simon S Wing
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

3.  Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.

Authors:  Chad A Corcoran; JoAnne Montalbano; Hong Sun; Qin He; Ying Huang; M Saeed Sheikh
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

4.  Proteasomal degradation unleashes the pro-death activity of androgen receptor.

Authors:  Bradley Godfrey; Yuting Lin; Jeffery Larson; Bonnie Haferkamp; Jialing Xiang
Journal:  Cell Res       Date:  2010-05-18       Impact factor: 25.617

Review 5.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

6.  Changes in Pirh2 and p27kip1 expression following traumatic brain injury in adult rats.

Authors:  Xiujie Wu; Wei Shi; Wei Zhao; Bai Shao; Qin Yuan; Chunmiao Li; Shuangwei Zhang; Binbin Sun; Qiyun Wu; Jian Chen
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

7.  Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.

Authors:  Mingzhou Chen; Jean-Claude Cortay; Ian R Logan; Vasileia Sapountzi; Craig N Robson; Denis Gerlier
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.

Authors:  Jong-Wei Hsu; Iawen Hsu; Defeng Xu; Hiroshi Miyamoto; Liang Liang; Xue-Ru Wu; Chih-Rong Shyr; Chawnshang Chang
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

9.  Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.

Authors:  Yuting Lin; Ziyan Lu; John Kokontis; Jialing Xiang
Journal:  Biochem Biophys Res Commun       Date:  2012-11-15       Impact factor: 3.575

10.  SCY1-like 1 binding protein 1 (SCYL1-bp1) interacts with p53-induced RING H2 protein (Pirh2) after traumatic brain injury in rats.

Authors:  Jian Chen; Feihui Zou; Hongran Fu; Hui Mao; Mingjie Gong; Lanchun Ni; Xide Xu; Jinlong Shi; Kaifu Ke; Maohong Cao; Fei Zhou; Wei Shi
Journal:  J Mol Histol       Date:  2013-03-12       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.